Literature DB >> 10844251

Characterization of subclones of the epithelial cell line from Chironomus tentans resistant to the insecticide RH 5992, a non-steroidal moulting hormone agonist.

M Grebe1, P Rauch, M Spindler-Barth.   

Abstract

Selection of hormone resistant subclones in the continuous presence of the insecticide and ecdysteroid mimick RH 5992 (tefubenozide) resulted preferentially in clones with defects in ecdysteroid receptor function. RH 5992 is already degraded to polar products in wild-type cells; no increase in metabolism of tefubenozide is observed in resistant clones. According to Western blots, ecdysteroid receptor (EcR) and its heterodimerization partner ultraspiracle (USP) are present in all resistant clones. The concentrations are comparable to wild-type cells, but in three clones the extent of phosphorylation of USP is diminished. With regard to hormone binding several types of hormone resistance are distinguished: (1) The same two high-affinity hormone recognition sites are present as in wild-type cells (K(D1)=0.31+/-0.28 nM, K(D2)=6.5+/-2.4 nM) but the number of binding sites is reduced. (2) The binding site with the lower affinity (K(D2)) is missing. (3) The binding site with the higher affinity (K(D1)) is missing. (4) No specific binding is observed. Ponasterone A binding can be rescued by addition of EcR but not by USP. (5) Ligand specificity is altered. RH 5992 can not compete [(3)H]-ponasterone A as efficient as in wild-type cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844251     DOI: 10.1016/s0965-1748(00)00032-1

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  2 in total

Review 1.  Ecdysteroid hormone action.

Authors:  Klaus-Dieter Spindler; C Hönl; Ch Tremmel; S Braun; H Ruff; M Spindler-Barth
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

2.  Cytoplasmic travels of the ecdysteroid receptor in target cells: pathways for both genomic and non-genomic actions.

Authors:  Xanthe Vafopoulou; Colin G H Steel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-23       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.